Deka Biosciences secures $20m to advance product pipeline

Deka Biosciences has secured funding of $20m in a Series B2 financing round to advance the product pipeline.

Sep 29, 2023 - 20:00

Deka Biosciences secures $20m to advance product pipeline

Deka Biosciences has secured funding of $20m in a Series B2 financing round to advance the product pipeline.

Read the original article

Tags:

Previous Article

HitGen and SGC enter drug discovery partnership

Gilead Abruptly Halts Phase 3 Leukemia Trial Following Disappointing Data

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

EU agencies back Covid-19 vaccine update ahead of autumn campaign

EU agencies back Covid-19 vaccine update ahead of autum...

Jun 7, 2023

Novartis eyes $2.9bn MorphoSys buyout to expand oncology pipeline

Novartis eyes $2.9bn MorphoSys buyout to expand oncolog...

Feb 6, 2024

AlphaMedix by Orano Med for Neuroendocrine Gastroentero...

Apr 23, 2024